The pathologist's role in rectal cancer patient assessments.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2789503)

Published in Clin Colon Rectal Surg on August 01, 2007

Authors

Joseph E Willis1

Author Affiliations

1: Department of Pathology, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. josephe.willis@uhhospitals.org

Articles cited by this

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07

Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med (1997) 9.99

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

Recurrence and survival after total mesorectal excision for rectal cancer. Lancet (1986) 8.16

The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg (1954) 6.74

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol (2005) 6.00

Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86

NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA (1990) 5.77

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68

Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst (2001) 5.68

The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology (1986) 3.70

A new prognostic classification of rectal cancer. Lancet (1987) 3.56

Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol (1996) 3.52

Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg (1995) 3.24

Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol (2002) 3.19

Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol (2002) 3.09

Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum (1993) 2.92

Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res (2005) 2.92

Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst (2005) 2.91

Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol (1986) 2.80

A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg (1985) 2.76

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76

The clinical significance of invasion of veins by rectal cancer. Br J Surg (1980) 2.69

Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg (2002) 2.46

A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum (2005) 2.45

Histopathology reporting in large bowel cancer. J Clin Pathol (1981) 2.43

Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. J Clin Oncol (2001) 2.43

Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol (1999) 2.40

Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum (1995) 2.39

For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer (1998) 2.16

The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology (1997) 2.11

From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol (1994) 2.09

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology (2005) 2.02

Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol (2003) 2.02

Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys (1998) 1.70

Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66

Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66

Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer (1994) 1.66

Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg (2002) 1.64

Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer (2002) 1.60

Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58

A synoptic reporting system for bone marrow aspiration and core biopsy specimens. Arch Pathol Lab Med (2006) 1.57

Pathology report in colon cancer: what is prognostically important? Dig Dis (1999) 1.57

Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol (2003) 1.54

Frozen section consultation. Utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol (1995) 1.54

Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol (2003) 1.51

The process for continuous improvement of the TNM classification. Cancer (2004) 1.49

Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg (1986) 1.46

Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol (2001) 1.42

Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology (1995) 1.42

Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum (1994) 1.42

Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage. Am J Clin Pathol (1999) 1.35

TNM classification: clarification of number of regional lymph nodes for pNo. Cancer (2001) 1.26

When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology (1986) 1.23

Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol (1992) 1.22

Signet-ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon Rectum (1999) 1.20

Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol (1999) 1.19

Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18

The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med (1992) 1.15

Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol (1999) 1.15

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum (2004) 1.15

Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum (2002) 1.13

Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med (2000) 1.13

Small cell neuroendocrine carcinoma of the rectum. Pathol Int (1995) 1.13

Protocol for the examination of specimens removed from patients with colorectal carcinoma. A basis for checklists. Cancer Committee, College of American Pathologists. Task Force for Protocols on the Examination of Specimens from Patients with Colorectal Cancer. Arch Pathol Lab Med (1994) 1.06

The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum (2001) 1.05

Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum (1983) 1.02

Small-cell carcinoma of the rectum: report of two cases. Dis Colon Rectum (1999) 1.02

Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg (1993) 1.00

Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients. Dis Colon Rectum (1997) 1.00

Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly. Surg Today (2005) 0.96

Small cell carcinoma of rectum: a case report. World J Gastroenterol (2005) 0.96

Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol (1999) 0.93

Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology (2004) 0.93

Colorectal carcinoma: importance of clinical and pathological factors in survival. Ann R Coll Surg Engl (1994) 0.87

Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann Surg (1991) 0.87

Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification. Dis Colon Rectum (1989) 0.85

The importance of accurate pathological assessment of lymph node involvement in colorectal cancer. Colorectal Dis (2006) 0.84

Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes. Cancer Detect Prev (2000) 0.83

What is the best way to predict disease-free survival after preoperative radiochemotherapy for rectal cancer patients: tumor regression grading, nodal status, or circumferential resection margin invasion? J Clin Oncol (2006) 0.78

Mechanised one-day fat clearance method to increase the lymph node yield in rectal cancer specimens. Br J Biomed Sci (2005) 0.76

Changes in the pathology reporting of rectal cancer: is it time to adopt synoptic reporting? N Z Med J (2003) 0.76